ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

SURVEY: Cognitive Impairment II

Top 3 Nutrients to Detox the Liver and Soothe Digestion

Natural Bladder Control, Go Less and Live More

Study bodes well for low-carb eaters

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Omega Fix for Obesity: How the Right Fats Fight Fat

Potential of Quercetin in the Treatment of Melanoma

How Pomegranate May Protect Against Cancer

Trimming the spare tire: Canola oil may cut belly fat

 
Print Page
Email Article

Results of Parkinson's study may change treatment

  [ 89 votes ]   [ Discuss This Article ]
www.ProHealth.com • August 8, 2000


Requip (ropinirole hydrochloride) successfully managed Parkinson's disease symptoms for up to five years with a low risk of developing dyskinesia, according to a study published in The New England Journal of Medicine. Dyskinesias are severe, uncontrollable, jerky body movements that plague many Parkinson's disease patients and in many cases are associated with L-dopa (l-dopa) therapy.

L-dopa has been the "gold standard" of treatment in Parkinson's disease for the past 35 years; it is used in approximately 75 percent of patients. Unfortunately, over time Parkinson's disease progresses and physicians need to increase the dosage and frequency of l-dopa to relieve Parkinson's symptoms.

Increasing the dosage of l-dopa can cause many patients to experience l-dopa-induced side effects such as dyskinesias, which can have a negative impact on a patient's ability to function. This study confirms that Requip, alone or in combination with low dose l-dopa, is effective in managing early Parkinson's disease (Hoehn & Yahr disease stages I-III).

"The impact of this study is that it will help guide physicians to chose among a number of Parkinson's disease treatments for early management in order to minimize the long-term side effects of treatment. And it indicates that if you use Requip first, you are less likely to get dyskinesias over the course of five years," said lead study author Olivier Rascol, M.D., Ph.D. of the Centre Hospitalier Universitaire Toulouse, France. "I think these results will impact physicians' treatment strategy to help improve the daily lives of patients coping with Parkinson's disease."

Requip is generally well tolerated. The most commonly reported side effects are nausea, somnolence, dizziness, headache and dyskinesia. Patients are advised to talk to their doctor about whether they have the potential to develop the sedating effects associated with Requip, which include somnolence, and the possibility of falling asleep while engaged in activities of daily living, including operation of a motor vehicle. Fainting or low blood pressure may occur during initial treatment or with an increase in dose. Hallucinations may occur at anytime during treatment. Requip may potentiate the side effects of L-dopa.

"The data confirm Requip's efficacy in the early stages of the disease with a low risk of developing dyskinesia and provide strong evidence in support of starting early Parkinson's disease patients on a dopamine agonist, such as Requip," said Ray Watts, M.D., Director of the Movement Disorders Program at Emory University School of Medicine. "A study is currently underway to determine if early treatment with Requip can have an effect on dopamine cell loss, which may be helpful in furthering our understanding of the progression of Parkinson's disease. Together, these studies may provide neurologists with a deeper understanding of how to optimally treat this condition."

Requip is a second-generation dopamine agonist indicated for the treatment of the signs and symptoms of both early and advanced stages of Parkinson's disease and was approved by the U.S. Food and Drug Administration (FDA) in September 1997.

A Progressive Neurodegenerative Disorder Parkinson's disease, which affects between 500,000 and one million Americans, is a chronic and progressive disorder that results from the death of nerve cells in a critical area of the brain called the substantia nigra. These nerve cells normally produce dopamine, a chemical messenger that plays an important role in motor movement control by transmitting signals between different areas of the brain. Increasing the dosage of l-dopa can cause many patients to experience l-dopa-induced side effects such as dyskinesias, which can have a negative impact on a patient's ability to function. Dopamine depletion results in a patient's impaired ability to control motor movements.

"Parkinson's disease affects nearly one million Americans, including Michael J. Fox, Janet Reno and Muhammad Ali," said Abraham Lieberman, M.D., Clinical Director for the National Parkinson Foundation. "If we can better treat the condition in the early stages, patients may be able to live more active lives. While searching for a cure to this disease, our hope is to better manage patients who are living with it now."



Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Ultra ATP+, Double Strength Optimized Curcumin Longvida®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Aches and Pains? A Simple Solution You'll Love Aches and Pains? A Simple Solution You'll Love
Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones
The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS
Coconut Oil - Healthy Gifts from the 'Tree of Life' Coconut Oil - Healthy Gifts from the 'Tree of Life'
How to Jump-start and Sustain Energy Production in CFS How to Jump-start and Sustain Energy Production in CFS

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map